Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 3:40 pm Sale |
2025-03-31 | 13G | UBS Group AG UBS |
Norges Bank | 139,886,962 4.000% |
-36,137,490 (-20.53%) |
Filing History |
| 2025-02-10 10:59 am Purchase |
2024-12-31 | 13G | Vipshop Holdings Limited VIPS |
UBS Group AG | 15,943,270 18.300% |
14,338,948 (+893.77%) |
Filing History |
| 2025-02-10 10:42 am Sale |
2024-12-31 | 13G | PIMCO Access Income Fund PAXS |
UBS Group AG | 2,233,985 5.100% |
-701,709 (-23.90%) |
Filing History |
| 2025-02-10 09:26 am Purchase |
2024-12-31 | 13G | RENALYTIX PLC ADS RNLXY |
UBS Group AG | 16,774,708 5.100% |
16,774,708 (New Position) |
Filing History |
| 2025-02-10 09:13 am Sale |
2024-12-31 | 13G | Liberty Broadband Corporation LBRDK |
UBS Group AG | 0 0.000% |
-7,781,165 (Position Closed) |
Filing History |
| 2025-02-10 08:59 am Sale |
2024-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
UBS Group AG | 0 0.000% |
-21,491,881 (Position Closed) |
Filing History |
| 2025-02-10 08:33 am Purchase |
2024-12-31 | 13G | Color Star Technology Co., Ltd. ADD |
UBS Group AG | 37,162 7.100% |
37,162 (New Position) |
Filing History |
| 2024-11-08 12:14 pm Purchase |
2024-09-30 | 13G | UBS Group AG UBS |
Norges Bank | 176,024,452 5.080% |
176,024,452 (New Position) |
Filing History |
| 2024-11-06 12:04 pm Purchase |
2024-09-30 | 13G | Infinera Corporation INFN |
UBS Group AG | 14,484,028 6.100% |
14,484,028 (New Position) |
Filing History |
| 2024-11-04 10:49 am Purchase |
2024-09-30 | 13G | Rapid7, Inc. RPD |
UBS Group AG | 3,941,537 6.300% |
3,941,537 (New Position) |
Filing History |
| 2024-11-01 09:00 am Purchase |
2024-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA |
UBS Group AG | 750,319 46.900% |
20,547 (+2.82%) |
Filing History |
| 2024-10-31 10:43 am Purchase |
2024-09-30 | 13G | Thornburg Income Builder Opportunities Trust TBLD |
UBS Group AG | 1,803,654 5.600% |
1,803,654 (New Position) |
Filing History |
| 2024-10-30 3:18 pm Sale |
2024-09-30 | 13G | Cohen & Steers Limited Duration Preferred and Income Fund, Inc. LDP |
UBS Group AG | 0 0.000% |
-1,474,839 (Position Closed) |
Filing History |
| 2024-10-30 11:30 am Purchase |
2024-09-30 | 13G | Liberty Broadband Corporation LBRDK |
UBS Group AG | 7,781,165 6.400% |
7,781,165 (New Position) |
Filing History |
| 2024-10-30 11:04 am Purchase |
2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
UBS Group AG | 21,491,881 6.900% |
21,491,881 (New Position) |
Filing History |
| 2024-08-08 12:55 pm Sale |
2024-06-30 | 13G | Sight Sciences, Inc. SGHT |
UBS Group AG | 0 0.000% |
-2,879,863 (Position Closed) |
Filing History |
| 2024-08-08 12:48 pm Sale |
2024-06-30 | 13G | The Marcus Corporation MCS |
UBS Group AG | 0 0.000% |
-1,299,728 (Position Closed) |
Filing History |
| 2024-08-08 11:36 am Unchanged |
2024-06-30 | 13G | ASLAN Pharmaceuticals Limited ASLN |
UBS Group AG | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-06-28 09:22 am Unchanged |
2024-06-28 | 13G | The Gabelli Dividend & Income Trust GDV |
UBS Group AG | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-06-28 09:11 am Unchanged |
2024-06-28 | 13G | The Gabelli Multimedia Trust Inc. GGT |
UBS Group AG | 0 0.000% |
0 (Unchanged) |
Filing History |